Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

EBITDA Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual EBITDA in 2023 was -14.56 Million USD , up 37.02% from previous year.
Medtecs International Corporation Limited's latest quarterly EBITDA in 2024 Q2 was -3.35 Million USD , up 79.49% from previous quarter.
Medtecs International Corporation Limited reported an annual EBITDA of -23.43 Million USD in 2022, down -197.14% from previous year.
Medtecs International Corporation Limited reported an annual EBITDA of 24.37 Million USD in 2021, down -83.15% from previous year.
Medtecs International Corporation Limited reported a quarterly EBITDA of N/A for 2023 FY, up 37.02% from previous quarter.
Medtecs International Corporation Limited reported a quarterly EBITDA of -4.41 Million USD for 2023 Q2, up 83.9% from previous quarter.

Annual EBITDA Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual EBITDA of Medtecs International Corporation Limited (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	-14.56 Million USD	37.02%
2022	-23.43 Million USD	-197.14%
2021	24.37 Million USD	-83.15%
2020	144.64 Million USD	1405.62%
2019	9.6 Million USD	21.48%
2018	5.05 Million USD	54.39%
2017	5.19 Million USD	-12.4%
2016	5.29 Million USD	-12.43%
2015	6.48 Million USD	-4.29%
2014	5.33 Million USD	4.35%
2013	5.78 Million USD	-13.86%
2012	7.69 Million USD	-19.14%
2011	7.56 Million USD	54.48%
2010	6.21 Million USD	-2.48%
2009	6.37 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-3.35 Million USD	79.49%
2023 FY	- USD	37.02%
2023 Q2	-4.41 Million USD	83.9%
2023 Q4	-16.34 Million USD	-270.0%
2022 Q2	-2.35 Million USD	-243.07%
2022 FY	- USD	-197.14%
2022 Q4	-27.43 Million USD	-1067.28%
2021 Q4	-685 Thousand USD	-103.36%
2021 Q2	20.37 Million USD	-78.76%
2021 FY	- USD	-83.15%
2020 Q2	44.24 Million USD	1484.25%
2020 Q4	95.92 Million USD	116.78%
2020 FY	- USD	1405.62%
2019 Q4	2.79 Million USD	10.22%
2019 Q2	2.53 Million USD	1.12%
2019 FY	- USD	21.48%
2018 Q4	2.5 Million USD	-1.61%
2018 FY	- USD	54.39%
2018 Q2	2.54 Million USD	19.07%
2017 Q4	2.13 Million USD	-29.91%
2017 Q2	3.05 Million USD	38.73%
2017 FY	- USD	-12.4%
2016 FY	- USD	-12.43%
2016 Q4	2.2 Million USD	-29.01%
2016 Q2	3.09 Million USD	10.84%
2015 FY	- USD	-4.29%
2015 Q4	2.79 Million USD	-24.27%
2015 Q2	3.69 Million USD	48.04%
2014 Q2	2.84 Million USD	32.51%
2014 FY	- USD	4.35%
2014 Q4	2.49 Million USD	-12.34%
2013 Q4	2.14 Million USD	-40.97%
2013 FY	- USD	-13.86%
2013 Q2	3.63 Million USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	- USD	-19.14%
2011 Q2	- USD	0.0%
2011 FY	- USD	54.48%
2011 Q4	- USD	0.0%
2010 FY	- USD	-2.48%
2010 Q4	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	- USD	0.0%

Peer EBITDA Comparison of Medtecs International Corporation Limited

Name	EBITDA	EBITDA Difference
Nang Kuang Pharmaceutical Co., Ltd.	402.69 Million TWD	103.617%
Maxigen Biotech Inc.	177.09 Million TWD	108.224%
SciVision Biotech Inc.	281.34 Million TWD	105.177%
Bionime Corporation	179.78 Million TWD	108.101%
Pegavision Corporation	2.91 Billion TWD	100.499%
Visco Vision Inc.	733.58 Million TWD	101.985%